Mammary stem cells and breast cancer

被引:42
作者
Molyneux, G. [1 ]
Regan, J. [1 ]
Smalley, M. J. [1 ]
机构
[1] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London SW3 6JB, England
关键词
breast; mammary; turnour; stem; estrogen receptor; CD24; CD44; CD133; Sca-1; field cancerisation;
D O I
10.1007/s00018-007-7391-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammary gland undergoes major developmental changes during puberty and pregnancy. It is thought that stem cells drive mammary gland development during puberty and are responsible for tissue maintenance as well as the major growth and remodelling that occurs with every pregnancy. The use of sophisticated cell separation procedures has facilitated the prospective isolation of mammary epithelial stem and differentiated cell subpopulations from the mouse mammary gland, while studies of primary human breast cancers have described subpopulations of tumourigenic cells capable of initiating tumour growth in immuno-compromised mice. These potential tumour 'stem cells' constitute an important therapeutic target population with respect to cancer therapy, as these are likely to be the cells which maintain tumour growth. Understanding the origin of these cells, their relationship to breast cancer subtypes, and how and why they differ from normal breast stem cells will lead to a revolution in tumour understanding, treatment and prevention.
引用
收藏
页码:3248 / 3260
页数:13
相关论文
共 112 条
[1]   Therapeutic targeting of a stem cell niche [J].
Adams, Gregor B. ;
Martin, Roderick P. ;
Alley, Ian R. ;
Chabner, Karissa T. ;
Cohen, Kenneth S. ;
Calvi, Laura M. ;
Kronenberg, Henry M. ;
Scadden, David T. .
NATURE BIOTECHNOLOGY, 2007, 25 (02) :238-243
[2]   CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells [J].
Aigner, S ;
Sthoeger, ZM ;
Fogel, M ;
Weber, E ;
Zarn, J ;
Ruppert, M ;
Zeller, Y ;
Vestweber, D ;
Stahel, R ;
Sammar, M ;
Altevogt, P .
BLOOD, 1997, 89 (09) :3385-3395
[3]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[4]  
Alvi AJ, 2003, BREAST CANCER RES, V5, DOI [10.1186/bcr563, 10.1186/bcr547]
[5]  
Anbazhagan R, 1998, J PATHOL, V184, P197, DOI 10.1002/(SICI)1096-9896(199802)184:2&lt
[6]  
197::AID-PATH992&gt
[7]  
3.0.CO
[8]  
2-J
[9]   Steroid hormone receptor status of mouse mammary stem cells [J].
Asselin-Labat, Marie-Liesse ;
Shackleton, Mark ;
Stingl, John ;
Vaillant, Francois ;
Forrest, Natasha C. ;
Eaves, Connie J. ;
Visvader, Jane E. ;
Lindeman, Geoffrey J. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (14) :1011-1014
[10]   Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype [J].
Balic, Marija ;
Lin, Henry ;
Young, Lillian ;
Hawes, Debra ;
Giuliano, Armando ;
McNamara, George ;
Datar, Ram H. ;
Cote, Richard J. .
CLINICAL CANCER RESEARCH, 2006, 12 (19) :5615-5621